Astrazeneca PLC (AZN) stock moves up, “Sell” rating reaffirmed by Goldman Sachs Group Inc. Analysts

Astrazeneca PLC (NYSE: AZN) shares rose yesterday on lower trade volume than normal after a number of analysts weighed in on the investing value of the stock and reiterated thier respective ratings.

Astrazeneca PLC (NYSE: AZN) had its Sell rating reiterated by equities researchers at Goldman Sachs Group Inc. in a research note to investors. Goldman Sachs Group Inc. currently has a rating of Sell on the stock. A number of other analysts have issued reports on the company recently, and Astrazeneca PLC has secured a consensus one-year price target of $36.09, above the opening price of $32.57, a difference of 11.07 percent. Astrazeneca PLC stock has a 52-week high of $35.04. Usually, after analysts assign a “reiterated rating” report on a stock, they will subsequently issue periodic updates, usually followed by a price target change.

Meanwhile, the Dow Jones Industrial Average DJIA, +0.62% finished up 112.58 points, or 0.6%, at 18,281.03 yesterday.

The Nasdaq Composite Index COMP, +0.50% rose 26.36 points, or 0.5%, to end at 5,316.02, and is up 0.1% for the week to date.

The S&P 500 index SPX, +0.43% added 9.24 points, or 0.4%, to close at 2,159.73.

Shares of Astrazeneca PLC (NYSE: AZN) opened at $32.57 yesterday and traded in a range between, $32.51 and $32.76, and last traded at $32.60, which is an increase of $0.03 or 0.00 over the previous closing price.

Astrazeneca PLC (NYSE: AZN) now has a market cap of 82.48B.

Astrazeneca PLCTrading Volume

4,338,650 shares crossed the trading desk yesterday, lower than normal, out of a total float 2,274,115,000. Look for trading volume to pick up in the coming days as momentum traders often use increases in trading volume to determine substantial volume accumulation or dissemination by institutional investors.

As with all possible breakouts, investors look for volume to be at least 40%-50% greater than normal on the breakout to show that fund managers and other professional investors are jumping in.

Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.

Institutional investors such as these retain teams of analysts that investigate thousands of stocks. So watching their interests is a good way to make sure you are buying the right stocks.

Astrazeneca PLC Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By identifying trends, moving averages allow traders to make those trends work in their favor and increase the number of winning trades.

Trades for Astrazeneca PLC (NYSE: AZN) have ranged from $26.97 – 35.04, and the stock now has a 50-day MA of $33.31 and 200-day MA of $30.75. Today’s last price is 0.07% below the 52 week high of $35.04.

Earnings growth is a critical factor to research when buying stocks and investors seek companies that have raised their earnings at least 25% or more over a 3 year period.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *